RAPT Therapeutics, Inc. (RAPT)
NASDAQ: RAPT · Real-Time Price · USD
10.65
+0.05 (0.47%)
Aug 14, 2025, 12:05 PM - Market open
RAPT Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Cash & Equivalents | 41.89 | 169.74 | 47.48 | 38.95 | 24.03 | 24.92 | Upgrade
|
| Short-Term Investments | 127.06 | 61.32 | 111.38 | 210.12 | 165.63 | 86.59 | Upgrade
|
| Cash & Short-Term Investments | 168.95 | 231.06 | 158.86 | 249.07 | 189.65 | 111.51 | Upgrade
|
| Cash Growth | 47.12% | 45.44% | -36.22% | 31.33% | 70.08% | 44.10% | Upgrade
|
| Prepaid Expenses | 3.91 | 4.18 | 2.92 | 3.63 | 3.32 | 4.09 | Upgrade
|
| Total Current Assets | 172.86 | 235.24 | 161.78 | 252.69 | 192.97 | 115.6 | Upgrade
|
| Property, Plant & Equipment | 3.28 | 4.7 | 7.68 | 9.48 | 2.74 | 2.98 | Upgrade
|
| Other Long-Term Assets | 2.27 | 0.39 | 3.87 | 4.04 | 2.92 | 0.39 | Upgrade
|
| Total Assets | 178.41 | 240.33 | 173.33 | 266.21 | 198.64 | 118.97 | Upgrade
|
| Accounts Payable | 4.19 | 1.28 | 5.18 | 3.37 | 2 | 2.38 | Upgrade
|
| Accrued Expenses | 6.58 | 44.6 | 14.1 | 8.66 | 6.33 | 4.94 | Upgrade
|
| Current Portion of Leases | 2.21 | 2.42 | 2.45 | 2.17 | - | - | Upgrade
|
| Current Unearned Revenue | - | - | - | - | 1.02 | 4.1 | Upgrade
|
| Other Current Liabilities | 0.07 | 0.06 | 0.11 | 0.03 | 0.25 | 0.33 | Upgrade
|
| Total Current Liabilities | 13.04 | 48.35 | 21.84 | 14.22 | 9.6 | 11.74 | Upgrade
|
| Long-Term Leases | 0.96 | 2.07 | 4.46 | 6.82 | - | - | Upgrade
|
| Long-Term Unearned Revenue | - | - | - | - | 0.51 | 0.86 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | 2.15 | 2.19 | Upgrade
|
| Total Liabilities | 14 | 50.42 | 26.29 | 21.04 | 12.26 | 14.79 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 813.73 | 804.39 | 631.61 | 613.07 | 470.63 | 319.2 | Upgrade
|
| Retained Earnings | -649.36 | -614.55 | -484.68 | -367.88 | -284.05 | -214.84 | Upgrade
|
| Comprehensive Income & Other | 0.02 | 0.05 | 0.1 | -0.03 | -0.21 | -0.18 | Upgrade
|
| Total Common Equity | 164.41 | 189.9 | 147.04 | 245.17 | 186.38 | 104.18 | Upgrade
|
| Shareholders' Equity | 164.41 | 189.9 | 147.04 | 245.17 | 186.38 | 104.18 | Upgrade
|
| Total Liabilities & Equity | 178.41 | 240.33 | 173.33 | 266.21 | 198.64 | 118.97 | Upgrade
|
| Total Debt | 3.16 | 4.49 | 6.91 | 8.99 | - | - | Upgrade
|
| Net Cash (Debt) | 165.78 | 226.56 | 151.96 | 240.08 | 189.65 | 111.51 | Upgrade
|
| Net Cash Growth | 51.94% | 49.10% | -36.71% | 26.59% | 70.08% | 44.10% | Upgrade
|
| Net Cash Per Share | 10.27 | 44.47 | 31.71 | 59.02 | 55.39 | 36.96 | Upgrade
|
| Filing Date Shares Outstanding | 16.54 | 16.5 | 4.35 | 4.29 | 3.7 | 3.11 | Upgrade
|
| Total Common Shares Outstanding | 16.54 | 16.5 | 4.3 | 4.28 | 3.69 | 3.1 | Upgrade
|
| Working Capital | 159.82 | 186.89 | 139.95 | 238.47 | 183.38 | 103.86 | Upgrade
|
| Book Value Per Share | 9.94 | 11.51 | 34.20 | 57.26 | 50.45 | 33.64 | Upgrade
|
| Tangible Book Value | 164.41 | 189.9 | 147.04 | 245.17 | 186.38 | 104.18 | Upgrade
|
| Tangible Book Value Per Share | 9.94 | 11.51 | 34.20 | 57.26 | 50.45 | 33.64 | Upgrade
|
| Machinery | 8.18 | 8.15 | 8.52 | 7.49 | 7.13 | 6.77 | Upgrade
|
| Leasehold Improvements | 3.3 | 3.3 | 3.3 | 3.3 | 3.3 | 3.29 | Upgrade
|
Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.